CERS: Cerus Corp Average Forecast Price

Corporate company logo of Cerus Corp. (CERS)

This daily price action for Cerus Corporation (CERS) reflects the dynamics of a global leader providing transfusion centers with reagents via a network of global hubs. The company's profitability, reaching 5.10, is based on the sale of plasma decontamination devices and components. Stringent regulatory blood safety requirements create significant barriers to entry for new market participants, guaranteeing stable profits for Cerus Corporation (CERS).

CERS: Cerus Price Target Chart 07/04/2022 - 11/12/2026

Analytical breakdowns for Cerus Corp (CERS)

- market price and analyst price targets:
Stock Quotes cerus.com|CERS - Analyst Consensus Forecast
- market capitalization information:
Market Value Cerus Corp|CERS - Total Company Value
- shareholders' equity book value data:
Accounting Value of a Share Cerus|CERS - Company Book Value|Market Capitalization to Book Value cerus.com|CERS - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Cerus Corporation|CERS - Long-Term Debt to Capital|Current Liabilities to Capital Cerus Inc|CERS - Company Aggregate Debts|Debt to Book Value Ratio Cerus Corp|CERS - Company Long-Term Debts|Short-Term Debt Volume Cerus|Quick Liquidity Indicator cerus.com
- earnings and valuation multiples information:
CERS - Net Profit|Projected Future Earnings Cerus Corporation|CERS - Price to Earnings Ratio|Future Price to Earnings Cerus Corp.|CERS - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Cerus Corp|CERS - Operating profit EBITDA|Net earnings per share for the last four quarters Cerus|CERS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months cerus.com|CERS - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Cerus Corporation
General company analysis:cerus.com (CERS)
Original product of Cerus

This indicator represents an averaged target share price benchmark that neutralizes the subjective deviations of individual experts to identify a sustainable market trend. Given the patent protection of INTERCEPT systems and the absence of price dumping, the history of expert consensus estimates allows investors to compare the fundamental value of Cerus Corporation (CERS) with current market expectations for the business's capitalization.

Competing companies

Consensus Target intuitive.com ISRG|Analyst Consensus Forecast DHR (Danaher)|BD (BDX) - Average Forecast Price|STE - Price Target Chart|Fair Value Consensus WST (West Pharma Corp)|Baxter International (BAX) - Price Target Chart|MASI - Analyst Median Target|Price Target Chart Stevanato Group|Consensus Target Teleflex Inc. (TFX)|Analyst Consensus Forecast MMSI|NVST - Average Forecast Price|Analyst Consensus Forecast ICUI (ICU Medical, Inc.)|XRAY: Broker Consensus Forecast|LeMaitre Vascular - Analyst Consensus Forecast|Analyst Median Target AtriCure Inc ATRC|STAA: Analyst Consensus Forecast|Consensus Target ChromaDex Corp.|ZIMV (ZimVie Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast angiodynamics.com|Price Target Chart Teknova (TKNO)|Price Target Chart MGRM (Monogram Technologies Inc.)|Sharps Technology - Consensus Target|Fair Value Consensus INFU|Utah Medical Products - Analyst Consensus Forecast|Analyst Median Target KORU Medical Systems KRMD|Nyxoah (NYXH) - Price Target Chart|Broker Consensus Forecast MBOT|Price Target Chart Pro-Dex Corp|Zentek Corp (ZTEK) - Analyst Median Target|Consensus Target ELUT (Elutia Inc.)|Analyst Forecast Prices MLSS|Price Target Chart NEXGEL NXGL|Fair Value Consensus RVP|HBIO: Consensus Target|FEMY - Analyst Consensus Forecast|meihuamed.com (MHUA) - Price Target Chart|Consensus Target Predictive Oncology Inc.|CJMB (Callan JMB Inc.) - Analyst Consensus Forecast|Average Forecast Price Atrion Corp. ATRI|Price Target Chart NeuroMetrix Corp (NURO)